07-25-2018 09:42 AM CET - Advertising, Media Consulting, Marketing Research
Print

Cancer Tumor Profiling Market is Driven with Growing Obligation and Dominated by (Qiagen N.V., F. Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc., Caris Life Sciences, Helomics Corp., NanoString T

Press release from: Data Bridge Market Research
Global Cancer Tumor Profiling Market
Global Cancer Tumor Profiling Market


Global Cancer Tumor Profiling Market report provides in-Depth analysis with current and upcoming Business opportunities to simplify the future investment in the market. The Global Cancer Tumor Profiling Market report presents an all-inclusive study of the market by survey the key expansion, development trends, driving forces, restraints, opportunities, and future potential in details.

Cancer Tumor Profiling Industry displays the production, revenue, price, and market share and growth rate 2025. Cancer Tumor Profiling Market provides study of Dominated Companies, Growth Drivers, Product Type, Applications, Classifications, End Users, Supply-Demand, regional output and Industry Chain Structure Forecast till 2025.

Get Free Sample Report@ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global Cancer Tumor Profiling Market accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Major Market Drivers and Restraints:

• Technological advancements for identifying the cancer tumors.
• Increasing the cancer incidences.
• Increase in demand for next generation sequencing technique in cancer profiling.
• Lack of Skilled Professionals and Infrastructure
• Growth in demand of personalized medicines
• Increase in the use of biomarkers in tumor profiling.
• Availability of Funding for Cancer Research

Market Segmentation:

The global cancer tumor profiling market is segmented by technology into:-

• Next-Generation Sequencing,
• Polymerase Chain Reaction,
• Immunohistochemistry,
• In Situ Hybridization and Microarray.
o Fluorescence In Situ Hybridization And
o Chromogenic In Situ Hybridization.

By Technique the market is segmented in:-

• Genomics,
• Proteomics,
• Epigenetics and
• Metabolomics.

By Application the market is segmented into:-

• Personalized Medicine,
• Diagnostics,
• Biomarker Discovery,
• Prognostics and
• Research Applications.

Inquiry Before buying: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Major Market Competitors:

Some of the major players operating in global cancer tumor profiling market are

• Illumina, Inc.,
• Qiagen N.V.,
• F. Hoffmann-La Roche AG,
• NeoGenomics Laboratories, Inc.,
• HTG Molecular Diagnostics, Inc.,
• Genomic Health Inc. ,
• Caris Life Sciences,
• Helomics Corp.,
• NanoString Technologies, Inc.,
• Oxford Gene Technology,
• Abbott,
• BD,
• Hologic, Inc.,
• Siemens Medical Solutions USA Inc.,
• Personal Genome Diagnostics, Inc.,
• FOUNDATION MEDICINE, INC.,
• Contextual Genomics,
• AGENDIA,
• Perthera, Inc.,
• ApoCell,
• GenScript,
• Ribomed,
• Boreal Genomics Inc.,
• Biotheranostics and
• Proteome Sciences among others.

Competitive Analysis:

The global cancer tumor profiling market is fragmented with the presence of a large number of players across different regions. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Reasons to Purchase this Report

• Current and future of global radiology services market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Access Full Report@ databridgemarketresearch.com/reports/global-cancer-tumor-...

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1144610 • Views: 189
More releasesMore releases

You can edit or delete your press release here: